CLX-0921 is an orally active PPARγ agonist, with an IC50 of 1.54 μM. It exhibits potent antihyperglycemic activity, making it a valuable tool for research in type 2 diabetes. This compound aids in the investigation of metabolic regulation and related therapeutic strategies in glucose homeostasis.
CLX-0921 is an orally active PPARγ agonist, with an IC50 of 1.54 μM. It exhibits potent antihyperglycemic activity, making it a valuable tool for research in type 2 diabetes. This compound aids in the investigation of metabolic regulation and related therapeutic strategies in glucose homeostasis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: